Hodgkin lymphoma

Dr. Stephen Ansell discusses research to develop new lymphoma therapies and the currently available nonchemotherapy treatment options.

Researchers found that the addition of brentuximab vedotin to standard chemotherapy improves overall survival in people with Hodgkin Lymphoma.